All Stories

  1. Dynamic modulation of the motor neuron translatome during developmental synapse elimination
  2. Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
  3. Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
  4. The systemic complexity of a monogenic disease: the molecular network of spinal muscular atrophy
  5. Patient-specific responses toSMN2splice-modifying treatments in spinal muscular atrophy fibroblasts
  6. Altered mitochondrial function in fibroblast cell lines derived from disease carriers of spinal muscular atrophy
  7. AI is a viable alternative to high throughput screening: a 318-target study
  8. Prevalence, clinical presentation, and etiology of myelopathies in 224 juvenile dogs
  9. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP‐43 overexpression mouse model of amyotrophic lateral sclerosis
  10. Response to letter regarding “SCN9A variant in a family of mixed breed dogs with congenital insensitivity to pain”
  11. A TNR Frameshift Variant in Weimaraner Dogs with an Exercise‐Induced Paroxysmal Movement Disorder
  12. Promoting good ethical practice
  13. SCN9A variant in a family of mixed breed dogs with congenital insensitivity to pain
  14. Successful conservative management of epidural gas accumulation and haematoma formation following a lateral corpectomy in a dog
  15. Otitis media and interna with or without polyps in cats: association between meningeal enhancement on postcontrast MRI, cerebrospinal fluid abnormalities, and clinician treatment choice and outcome
  16. Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis
  17. Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine
  18. Cerebrospinal fluid analysis in dogs: Main patterns and prevalence of albuminocytological dissociation
  19. A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I
  20. What Is Your Neurologic Diagnosis?
  21. Pre-natal manifestation of systemic developmental abnormalities in spinal muscular atrophy
  22. Renal pathology in a mouse model of severe Spinal Muscular Atrophy is associated with downregulation of Glial Cell-Line Derived Neurotrophic Factor (GDNF)
  23. A comprehensive biomedical variant catalogue based on whole genome sequences of 582 dogs and eight wolves
  24. Variation in the position of the conus medullaris and dural sac in adult dogs
  25. The role of survival motor neuron protein (SMN) in protein homeostasis
  26. An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers
  27. Impaired cardiac contractile function in arginine:glycine amidinotransferase knockout mice devoid of creatine is rescued by homoarginine but not creatine
  28. Proof of concept and feasibility studies examining the influence of combination ribose, adenine and allopurinol treatment on stroke outcome in the rat
  29. The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease?
  30. Movement disorder in young weimaraners
  31. The neuronal ceroid lipofuscinoses: Opportunities from model systems
  32. Refinement of analgesia following thoracotomy and experimental myocardial infarction using the Mouse Grimace Scale
  33. A review of canine atlantoaxial joint subluxation
  34. Myocardial Creatine Levels Do Not Influence Response to Acute Oxidative Stress in Isolated Perfused Heart
  35. Computer-Assisted Radiographic Calculation of Spinal Curvature in Brachycephalic “Screw-Tailed” Dog Breeds with Congenital Thoracic Vertebral Malformations: Reliability and Clinical Evaluation
  36. Diagnostic Exercise
  37. The effect of kyphoscoliosis on intervertebral disc degeneration in dogs
  38. A PROPOSED RADIOGRAPHIC CLASSIFICATION SCHEME FOR CONGENITAL THORACIC VERTEBRAL MALFORMATIONS IN BRACHYCEPHALIC “SCREW-TAILED” DOG BREEDS
  39. Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse Heart
  40. 1H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism
  41. Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction